Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

284 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 284 results

Large-scale testing (Phase 3)Study completedNCT00210873
What this trial is testing

An Open Label Extension of a Study of Topiramate in Chronic Migraine.

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 200
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT02409134
What this trial is testing

Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat

Who this might be right for
Quality of LifeGraft-vs-Host Disease
Sung Choi, M.D. 9
Testing effectiveness (Phase 2)Ended earlyNCT06271616
What this trial is testing

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 2
Early research (Phase 1)Looking for participantsNCT07025538
What this trial is testing

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
City of Hope Medical Center 42
Early research (Phase 1)Study completedNCT02728895
What this trial is testing

Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Takeda 24
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01665677
What this trial is testing

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host Disease
Mehdi Hamadani 69
Testing effectiveness (Phase 2)Study completedNCT03680092
What this trial is testing

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Who this might be right for
GVHDHematologic Neoplasms
Dimitrios Tzachanis, MD PhD 43
Post-approval studies (Phase 4)Study completedNCT01883180
What this trial is testing

ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell TransplantationAntithymocyte GlobulinViral Infection
Nanfang Hospital, Southern Medical University 412
Not applicableStudy completedNCT04838704
What this trial is testing

Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Versus Host Disease
Zhejiang University 215
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Testing effectiveness (Phase 2)Ended earlyNCT00623012
What this trial is testing

Rapamycin for Prevention of Chronic Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Yale University 2
Testing effectiveness (Phase 2)Study completedNCT00886522
What this trial is testing

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

Who this might be right for
Hematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 23
Testing effectiveness (Phase 2)Ended earlyNCT02167451
What this trial is testing

Maraviroc as GVHD Prophylaxis in Transplant Recipients

Who this might be right for
Diagnoses That Require Stem Cell TransplantGraft Versus Host Disease (GVHD)
Children's Hospital Medical Center, Cincinnati 31
Large-scale testing (Phase 3)Study completedNCT00678275
What this trial is testing

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 161
Early research (Phase 1)Study completedNCT00001830
What this trial is testing

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more
National Cancer Institute (NCI) 110
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Testing effectiveness (Phase 2)Study completedNCT02588339
What this trial is testing

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Who this might be right for
Graft Versus Host DiseaseGVHD
H. Lee Moffitt Cancer Center and Research Institute 42
Load More Results